Entereg (alvimopan) is the first and only FDA-approved agent indicated to accelerate the time to gastrointestinal (GI) recovery following surgeries that include partial bowel resection with primary anastomosis.
Scope of the Report:
The global Entereg (alvimopan) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Entereg (alvimopan).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Entereg (alvimopan) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Entereg (alvimopan) market by product type and applications/end industries.
Market Segment by Companies, this report covers
Merck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
12 mg Capsule
Type II
Market Segment by Applications, can be divided into
Partial bowel resection
Radical cystectomy
Table of Contents
1 Entereg (alvimopan) Market Overview
1.1 Product Overview and Scope of Entereg (alvimopan)
1.2 Classification of Entereg (alvimopan) by Types
1.2.1 Global Entereg (alvimopan) Revenue Comparison by Types (2019-2024)
1.2.2 Global Entereg (alvimopan) Revenue Market Share by Types in 2018
1.2.3 12 mg Capsule
1.2.4 Type II
1.3 Global Entereg (alvimopan) Market by Application
1.3.1 Global Entereg (alvimopan) Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Partial bowel resection
1.3.3 Radical cystectomy
1.4 Global Entereg (alvimopan) Market by Regions
1.4.1 Global Entereg (alvimopan) Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Entereg (alvimopan) Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Entereg (alvimopan) Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Entereg (alvimopan) Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Entereg (alvimopan) Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Entereg (alvimopan) Status and Prospect (2014-2024)
1.5 Global Market Size of Entereg (alvimopan) (2014-2024)
Summary: Get latest Market Research Reports on Entereg (alvimopan). Industry analysis & Market Report on Entereg (alvimopan) is a syndicated market report, published as Global Entereg (alvimopan) Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Entereg (alvimopan) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.